Sugi Predict

Sugi Predict / Compounds / Ether

Ether

Ether

SCHEMBL2390477

CCCCCCCCCCCCOCC(O)CO.CCOCC

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 1/20 0.89
▸ HTT P42858 2/20 0.62
▸ LPAR5 Q9H1C0 4/20 0.54
▸ PLA2G2C Q5R387 1/20 0.52
▸ MEN1 O00255 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ SPHK1 Q9NYA1 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ DUSP3 P51452 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ THRB P10828 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ LPAR1 Q92633 5/20 0.42
▸ LPAR3 Q9UBY5 5/20 0.42
▸ LPAR2 Q9HBW0 4/20 0.42
▸ LPAR6 P43657 3/20 0.42
▸ LPAR4 Q99677 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Batilol SCHEMBL940982 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL6805057 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL2015031 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL93806 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL8501744 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL6428915 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL8502252 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL3811088 1.00 USP2 (0.89) USP2HTTLPAR5PLA2G2CMEN1
Ether SCHEMBL8501725 0.98 USP2 (0.85) USP2HTTLPAR5PLA2G2CMEN1
SCHEMBL24835077 0.94 USP2 (1.00) USP2HTTLPAR5PLA2G2CMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107106663-B Compositions and kits for enzymatic debridement and methods of use thereof 罗查尔科技有限责任公司 2022-12-06 — — CN claimed
WO-2020186979-A1 PROTECTIVE TOOL, STERILISING AND DISINFECTING COMPOSITE SHEET MATERIAL, AND MANUFACTURING METHOD THEREFOR 深圳市康风环境科技发展有限公司 2020-09-24 — — WO claimed
EP-2594248-B1 Active ingredient combination and use thereof Air Liquide Santé (International) (FR) 2016-12-14 — — EP claimed
EP-1683416-B1 Alcoholic compositions for disinfection AIR LIQUIDE SANTÉ INTERNATIONAL (FR) 2015-12-09 — — EP claimed
US-20040208783-A1 Process for the chemical and thermal disinfection AIR LIQUIDE SANTE (INTERNATIONAL ) (FR) 2004-10-21 — — US claimed
EP-1468606-A1 Process for the chemical and thermal disinfection Air Liquide Santé (International) (FR) 2004-10-20 — — EP claimed
CN-107106663-B Compositions and kits for enzymatic debridement and methods of use thereof 罗查尔科技有限责任公司 2022-12-06 — — CN disclosed
WO-2020186979-A1 PROTECTIVE TOOL, STERILISING AND DISINFECTING COMPOSITE SHEET MATERIAL, AND MANUFACTURING METHOD THEREFOR 深圳市康风环境科技发展有限公司 2020-09-24 — — WO disclosed
CN-108951186-A A kind of manufacturing method of full aqueous ultrafine fiber synthetic leather 陕西科技大学 2018-12-07 — — CN disclosed
CN-108603137-A Low shear strength lubricating fluids 桑托管业有限责任公司 2018-09-28 — — CN disclosed
CN-108367173-A For making cosmetics corrosion-resistant liquid concentrate 奇科迈尔有限公司 2018-08-03 — — CN disclosed
EP-1683416-B1 Alcoholic compositions for disinfection AIR LIQUIDE SANTÉ INTERNATIONAL (FR) 2015-12-09 — — EP disclosed
US-20110237626-A1 COMPOSITIONS FOR HYGIENIC HAND DISINFECTION AND DISINFECTANT HANDWASHING AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2011-09-29 — — US disclosed
US-20050043402-A1 Methods and formulations for counteracting infection of mucosa or skin LIPOMEDICA EHF. (IS) 2005-02-24 — — US disclosed
US-6596763-B1 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous LIPOMEDICA EHF. (IS) 2003-07-22 — — US disclosed
EP-0941087-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS Thormar, Halldor (IS) 1999-09-15 — — EP disclosed
WO-1998020872-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS THORMAR HALLDOR (IS) 1998-05-22 — — WO disclosed
US-5705182-A BACTERICIDES ADDED TO TAMPONS MCNEIL-PPC, INC. (US) 1998-01-06 — — US disclosed
US-5679369-A MONO- AND DIESTERS OF POLYHYDRIC ALIPHATIC ALCOHOL AND A FATTY ACID; PREVENTION OF TOXIC SHOCK SYNDROME MCNEIL-PPC, INC. (US) 1997-10-21 — — US disclosed
US-5641503-A Additives to tampons MCNEIL-PPC, INC. (US) 1997-06-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043402-A1 Methods and formulations for counteracting infection of mucosa or skin MGLL, GK, UGCG USP2 1597/4885HTT 3992/4885LPAR5 763/4885
US-20110237626-A1 COMPOSITIONS FOR HYGIENIC HAND DISINFECTION AND DISINFECTANT HANDWASHING DHCR24, DEGS1, ADH1C USP2 279/4885HTT 1984/4885LPAR5 2428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.